EUVIMEDEUVIMED entdecken
Crossref

Engineered Bio‐Heterojunction with Robust ROS‐Scavenging and Anti‐Inflammation for Targeted Acute Pancreatitis Therapy

Hongxing Shi, Yaoyu Guo, Chong Geng, Lin Chen, Shuai He, Wenxuan He, Yanbai Chen, Yau Kei Chan, Chunhui Wang, Yi Deng

Advanced Functional Materials · 2025-01 · 35 (3)

DOI: 10.1002/adfm.202413276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 12.10.2024. Verfasst von Hongxing Shi und 9 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Natural Science Foundation of Sichuan Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute pancreatitis (AP) is one of the most severe mortal inflammatory diseases worldwide, which is characterized by the over‐activation of reactive oxygen species (ROS)‐induced inflammation and pancreatic enzymes (PEs). As the PEs induced by ROS exacerbate the progression of AP, therefore, scavenging ROS within PEs is a prerequisite for AP treatment. To address the daunting issue, the engineered bio‐heterojunctions (bio‐HJs) consisting of Mo 2 C‐Au (MA), phospholipid, and protease inhibitors are devised. First, the decorated phospholipid and protease inhibitors facilitate the delivery of MA to the inflammatory pancreas as well as neutralization of PEs. Next, the MA exhibits outstanding antioxidant and ROS scavenging abilities, primarily benefiting from the increased empty orbitals on Mo attributed to electron transfer between the Mo 2 C and Au confirmed by theoretical calculation. The in vitro experiments demonstrate that the bio‐HJs exhibit splendid biocompatibility, excellent trypsin neutralization, and efficient ROS elimination properties. More encouragingly, the in vivo studies further reveal that the bio‐HJs prevent the infiltration of inflammatory cells and alleviate the severity of AP by suppressing the ROS‐induced activation of the TLR4‐ERK1/2 MAPK‐MLCK inflammatory signaling pathway. As envisioned, the engineered bio‐HJs represent a promising approach to the treatment and prevention of AP.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Shi, H., Guo, Y., Geng, C., Chen, L., He, S., He, W., Chen, Y., Chan, Y. K., Wang, C., & Deng, Y. (2025). Engineered Bio‐Heterojunction with Robust ROS‐Scavenging and Anti‐Inflammation for Targeted Acute Pancreatitis Therapy. Advanced Functional Materials, 35(3). https://doi.org/10.1002/adfm.202413276

Vancouver

Shi H, Guo Y, Geng C, Chen L, He S, He W, et al. Engineered Bio‐Heterojunction with Robust ROS‐Scavenging and Anti‐Inflammation for Targeted Acute Pancreatitis Therapy. Advanced Functional Materials. 2025;35(3). doi:10.1002/adfm.202413276

BibTeX
@article{Shi2025,
  author = {Shi, Hongxing and Guo, Yaoyu and Geng, Chong and Chen, Lin and He, Shuai and He, Wenxuan and Chen, Yanbai and Chan, Yau Kei and Wang, Chunhui and Deng, Yi},
  title = {Engineered Bio‐Heterojunction with Robust ROS‐Scavenging and Anti‐Inflammation for Targeted Acute Pancreatitis Therapy},
  journal = {Advanced Functional Materials},
  year = {2025},
  volume = {35},
  number = {3},
  doi = {10.1002/adfm.202413276}
}
Kostenlos starten →